Autologous cervical tumor lysate pulsed dendritic cell stimulation followed by cisplatin treatment abrogates FOXP3+ cells in vitro

OBJECTIVE: Dendritic cells (DCs) are administered as immunotherapeutic adjuvants after the completion of standard treatment in most settings. However, our Phase I trial indicated that one patient out of four, who received autologous tumor lysate-pulsed dendritic cell (TLDC) also received cisplatin c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Gynecol Oncol
Main Authors: Dhandapani, Hemavathi, Seetharaman, Abirami, Jayakumar, Hascitha, Ganeshrajah, Selvaluxmy, Singh, Shirley Sunder, Thangarajan, Rajkumar, Ramanathan, Priya
Formato: Artigo
Idioma:Inglês
Publicado em: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8192235/
https://ncbi.nlm.nih.gov/pubmed/33908712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2021.32.e59
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados